Logo image of NVX

NOVONIX LTD-ADR (NVX) Stock Fundamental Analysis

USA - NASDAQ:NVX - US67010L1008 - ADR

1.98 USD
+0.02 (+1.02%)
Last: 10/17/2025, 8:00:02 PM
2.0001 USD
+0.02 (+1.02%)
After Hours: 10/17/2025, 8:00:02 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to NVX. NVX was compared to 123 industry peers in the Electronic Equipment, Instruments & Components industry. Both the profitability and financial health of NVX have multiple concerns. NVX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year NVX has reported negative net income.
In the past year NVX has reported a negative cash flow from operations.
In the past 5 years NVX always reported negative net income.
In the past 5 years NVX always reported negative operating cash flow.
NVX Yearly Net Income VS EBIT VS OCF VS FCFNVX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

NVX has a worse Return On Assets (-27.71%) than 74.19% of its industry peers.
NVX's Return On Equity of -46.06% is on the low side compared to the rest of the industry. NVX is outperformed by 74.19% of its industry peers.
Industry RankSector Rank
ROA -27.71%
ROE -46.06%
ROIC N/A
ROA(3y)-22.59%
ROA(5y)-20.43%
ROE(3y)-33.39%
ROE(5y)-27.76%
ROIC(3y)N/A
ROIC(5y)N/A
NVX Yearly ROA, ROE, ROICNVX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

NVX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NVX Yearly Profit, Operating, Gross MarginsNVX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2K -4K -6K

More info and screens

1

2. Health

2.1 Basic Checks

NVX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NVX has been increased compared to 1 year ago.
NVX has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, NVX has a worse debt to assets ratio.
NVX Yearly Shares OutstandingNVX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
NVX Yearly Total Debt VS Total AssetsNVX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

Based on the Altman-Z score of 0.00, we must say that NVX is in the distress zone and has some risk of bankruptcy.
NVX has a Altman-Z score of 0.00. This is in the lower half of the industry: NVX underperforms 78.23% of its industry peers.
NVX has a Debt/Equity ratio of 0.27. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.27, NVX is in line with its industry, outperforming 41.13% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Altman-Z 0
ROIC/WACCN/A
WACC8.74%
NVX Yearly LT Debt VS Equity VS FCFNVX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

A Current Ratio of 0.93 indicates that NVX may have some problems paying its short term obligations.
NVX has a Current ratio of 0.93. This is amonst the worse of the industry: NVX underperforms 92.74% of its industry peers.
NVX has a Quick Ratio of 0.93. This is a bad value and indicates that NVX is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.90, NVX is not doing good in the industry: 83.06% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.9
NVX Yearly Current Assets VS Current LiabilitesNVX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

5

3. Growth

3.1 Past

NVX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -28.68%.
NVX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -24.01%.
Measured over the past years, NVX shows a very strong growth in Revenue. The Revenue has been growing by 20.91% on average per year.
EPS 1Y (TTM)-28.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.32%
Revenue 1Y (TTM)-24.01%
Revenue growth 3Y13.64%
Revenue growth 5Y20.91%
Sales Q2Q%-23.25%

3.2 Future

NVX is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -28.70% yearly.
NVX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 66.08% yearly.
EPS Next Y26.19%
EPS Next 2Y20.27%
EPS Next 3Y21.99%
EPS Next 5Y-28.7%
Revenue Next Year2.09%
Revenue Next 2Y284.07%
Revenue Next 3Y204.67%
Revenue Next 5Y66.08%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NVX Yearly Revenue VS EstimatesNVX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M
NVX Yearly EPS VS EstimatesNVX Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -0.5 -1 -1.5 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

NVX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NVX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NVX Price Earnings VS Forward Price EarningsNVX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NVX Per share dataNVX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

A more expensive valuation may be justified as NVX's earnings are expected to grow with 21.99% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.27%
EPS Next 3Y21.99%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NVX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NOVONIX LTD-ADR

NASDAQ:NVX (10/17/2025, 8:00:02 PM)

After market: 2.0001 +0.02 (+1.02%)

1.98

+0.02 (+1.02%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)08-20 2025-08-20
Earnings (Next)02-26 2026-02-26/amc
Inst Owners7.55%
Inst Owner Change0%
Ins Owners3.37%
Ins Owner ChangeN/A
Market Cap358.35M
Analysts84
Price Target1.63 (-17.68%)
Short Float %0.22%
Short Ratio1.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.85%
PT rev (3m)5.47%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)35.57%
EPS NY rev (3m)20%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)59.55%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 55.84
P/FCF N/A
P/OCF N/A
P/B 2.3
P/tB 2.51
EV/EBITDA N/A
EPS(TTM)-0.46
EYN/A
EPS(NY)-0.35
Fwd EYN/A
FCF(TTM)-0.57
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS0.04
BVpS0.86
TBVpS0.79
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.71%
ROE -46.06%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-22.59%
ROA(5y)-20.43%
ROE(3y)-33.39%
ROE(5y)-27.76%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 918.33%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.93
Quick Ratio 0.9
Altman-Z 0
F-Score2
WACC8.74%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)612.3%
Cap/Sales(5y)467.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-28.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.32%
EPS Next Y26.19%
EPS Next 2Y20.27%
EPS Next 3Y21.99%
EPS Next 5Y-28.7%
Revenue 1Y (TTM)-24.01%
Revenue growth 3Y13.64%
Revenue growth 5Y20.91%
Sales Q2Q%-23.25%
Revenue Next Year2.09%
Revenue Next 2Y284.07%
Revenue Next 3Y204.67%
Revenue Next 5Y66.08%
EBIT growth 1Y-1.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year22.7%
EBIT Next 3Y33.82%
EBIT Next 5Y13.32%
FCF growth 1Y-371.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-276.15%
OCF growth 3YN/A
OCF growth 5YN/A